• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    PureTech Health to Present at the Jefferies 2016 Healthcare Conference

    Chelsea Pratt
    Nov. 02, 2016 02:10AM PST
    Biotech Investing

    PureTech Health, across-disciplinary biotech company developing 21st century medicines, today announced that Daphne Zohar, PureTech Health’s Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference.

    PureTech Health plc (“PureTech” or the “Company”, LSE: PRTC), a cross-disciplinary biotech company developing 21st century medicines, today announced that Daphne Zohar, PureTech Health’s Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Wednesday, November 16, at 4:00pm GMT.
    A webcast of the presentation will be available at https://puretechhealth.com/investors.php
    under the Reports and Presentations tab.
    About PureTech Health
    PureTech
    Health
    (PureTech Health plc, PRTC.L) is a cross-disciplinary biotech
    company creating 21st century medicines that modulate the
    adaptive human systems. Our therapies target the immune, nervous, and
    gastro-intestinal systems by addressing the underlying pathophysiology
    of disease from a systems perspective rather than through a single
    receptor or pathway. We are advancing more than 20 clinical studies
    across our pipeline, with five human proof-of-concept studies and
    multiple pivotal or registration studies expected to read out in the
    next two years. PureTech Health’s rich and growing research and
    development pipeline has been developed in collaboration with some of
    the world’s leading scientific experts, who along with PureTech’s
    experienced team and board analyze more than 650 scientific discoveries
    per year to identify and advance the opportunities we believe hold the
    most promise for patients. This process places PureTech Health on the
    cutting edge of ground-breaking science and technological innovation and
    leads the Company between and beyond existing disciplines. For more
    information, visit www.puretechhealth.com
    or connect with us on Twitter.
    Forward Looking Statement
    This press release contains
    statements that are or may be forward-looking statements, including
    statements that relate to the company’s future prospects, developments
    and strategies. The forward- looking statements are based on current
    expectations and are subject to known and unknown risks and
    uncertainties that could cause actual results, performance and
    achievements to differ materially from current expectations, including,
    but not limited to, those risks and uncertainties described in the risk
    factors included in the company’s regulatory filings. These
    forward-looking statements are based on assumptions regarding the
    present and future business strategies of the company and the
    environment in which it will operate in the future. Each forward-looking
    statement speaks only as at the date of this press release. Except as
    required by law, regulatory requirement, the Listing Rules and the
    Disclosure and Transparency Rules, neither the company nor any other
    party intends to update or revise these forward- looking statements,
    whether as a result of new information, future events or otherwise.

    clinical studieshealthcare conferencepuretech health
    The Conversation (0)

    Go Deeper

    AI Powered
    Test tubes.

    Biotech Market Forecast: Top Trends for Biotech in 2025

    Dyne Therapeutics to Present at Jefferies Global Healthcare Conference

    Dyne Therapeutics to Present at Jefferies Global Healthcare Conference

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES